Fosaprepitant dimeglumine and Duodenal ulcer aggravated - a phase IV clinical study of FDA data

Summary:

Duodenal ulcer aggravated is reported as a side effect among people who take Fosaprepitant dimeglumine (fosaprepitant dimeglumine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Aloxi, and have Pain.

The phase IV clinical study analyzes which people have Duodenal ulcer aggravated when taking Fosaprepitant dimeglumine. It is created by eHealthMe based on reports of 1,528 people who have side effects when taking Fosaprepitant dimeglumine from the FDA, and is updated regularly.

What is Fosaprepitant dimeglumine?

Fosaprepitant dimeglumine has active ingredients of fosaprepitant dimeglumine. eHealthMe is studying from 1,528 Fosaprepitant dimeglumine users. Check the latest studies of Fosaprepitant dimeglumine.

What is Duodenal ulcer aggravated?

Duodenal ulcer aggravated is found to be associated with 1,490 drugs and 524 conditions by eHealthMe. Check the latest studies of Duodenal ulcer aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,528 people reported to have side effects when taking Fosaprepitant dimeglumine.
Among them, 14 people (0.92%) have Duodenal ulcer aggravated.

Could Fosaprepitant dimeglumine cause Duodenal ulcer aggravated?

Among these 14 people:

How long have people been on Fosaprepitant dimeglumine when they have Duodenal ulcer aggravated? *

What is the gender of people who have Duodenal ulcer aggravated when taking Fosaprepitant dimeglumine? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Duodenal ulcer aggravated when taking Fosaprepitant dimeglumine? *

What are other drugs people take besides Fosaprepitant dimeglumine? *

What are other side effects people have besides Duodenal ulcer aggravated? *

Nausea (feeling of having an urge to vomit): 4 people, 28.57%
Dyspnea (difficult or laboured breathing): 4 people, 28.57%
Arrhythmias (irregular heartbeat): 3 people, 21.43%
Oedema (fluid collection in tissue): 3 people, 21.43%
Depressed Level Of Consciousness: 3 people, 21.43%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 3 people, 21.43%
Insomnia (sleeplessness): 3 people, 21.43%
High Blood Pressure: 3 people, 21.43%
Delirium (wild excitement): 3 people, 21.43%
Fainting (loss of consciousness and postural tone): 3 people, 21.43%

What are the existing conditions these people have? *

Pain: 5 people, 35.71%
Back Pain: 4 people, 28.57%
Constipation: 4 people, 28.57%
Hypotension (abnormally low blood pressure): 3 people, 21.43%
Lymphoma (cancer that begins in immune system cells): 3 people, 21.43%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 21.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 21.43%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 21.43%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Fosaprepitant dimeglumine and have Duodenal ulcer aggravated?

- Check whether Duodenal ulcer aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosaprepitant dimeglumine:

Fosaprepitant dimeglumine (1,528 reports)

Browse all side effects of Fosaprepitant dimeglumine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (1,490 drugs)

Browse all the conditions that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (524 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosaprepitant dimeglumine (the active ingredients of Fosaprepitant dimeglumine) and Fosaprepitant dimeglumine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.